April 2022

Effective Obesity Treatment Critical in Avoiding Cost

The obesity epidemic is driving up both the rate of other chronic diseases and the costs associated with treating them, according to Melanie Smith, MD, a Diplomate in obesity medicine at Advocate Aurora. Obesity, she said, is the greatest risk factor contributing to the burden of chronic disease and it is responsible for over $480 billion in direct health care costs.

Samantha Pabich MD, an assistant professor at the University of Wisconsin and endocrinologist at UW Health, joined Dr. Smith at the WCHQ March 23 webinar, “Obesity Treatment: A Pathway to a Healthier Wisconsin.” The webinar drew more than 150 registrations.

Dr. Smith noted that in New York City the second strongest predictor of COVID hospitalizations in the early months of the pandemic after advanced age was obesity. A patient being treated for COVID with a BMI over 35 was seven times more likely to be intubated than those with a normal BMI.

Pabich pointed out that modest weight loss can significantly improve a person’s health. She is pleased that Wisconsin has clinical trials in place for diabetes and obesity, which is an indicator that these diseases are important and that will lead to better care of patients with these conditions.

“When two-thirds of the population is carrying more weight than recommended, then it cannot possibly be just an individual problem,” according to Pabich.

Jen Koberstein, WCHQ program manager, leads the WCHQ Obesity Advisory Group with support from Novo Nordisk. Started in early 2021, the Obesity Advisory Group has helped design and develop content for an education series on obesity for employers aimed at building awareness of obesity as a chronic disease and the importance of including this coverage in their employee health plan. The group is also planning the statewide Obesity Summit October 13, 2022, in Fond du Lac.

The WCHQ Obesity Advisory Group is open to all WCHQ provider members. To learn more, contact Jen Koberstein.